Immunomodulatory effects of interferon-γ on human fetal cardiac mesenchymal stromal cells

by Karl-Henrik Grinnemo, Marie Löfling, Lubov Nathanson, Roland Baumgartner, Daniel F. J. Ketelhuth, Vladimir Beljanski, Lindsay C. Davies, Cecilia Österholm
Published 2019-12-01

Correlation Between Tumor-Associated Macrophage and Immune Checkpoint Molecule Expression and Its Prognostic Significance in Cutaneous Melanoma

by Young Jae Kim, Chong Hyun Won, Mi Woo Lee, Jee Ho Choi, Sung Eun Chang, Woo Jin Lee
Published 2020-08-01

Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations

by Jiqiao Yang, Jiqiao Yang, Jiqiao Yang, Xiujing He, Xiujing He, Qing Lv, Qing Lv, Jing Jing, Hubing Shi, Hubing Shi
Published 2019-07-01

Chinese Experts Consensus on Immune Checkpoint Inhibitors 
for Non-small Cell Lung Cancer (2020 Version)

by Caicun ZHOU, Jie WANG, Baocheng WANG, Ying CHENG, Zhehai WANG, Baohui HAN, You LU, Gang WU, Li ZHANG, Yong SONG, Bo ZHU, Yi HU, Ziping WANG, Qibin SONG, Shengxiang REN, Yayi HE, Xiaohua HU, Jian ZHANG, Yu YAO, Hongyun ZHAO, Zhijie WANG, Qian CHU, Jianchun DUAN, Jingjing LIU, Shukui QIN
Published 2021-04-01

Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

by Mei J, Li SH, Li QJ, Sun XQ, Lu LH, Lin WP, Zheng L, Chen MS, Shi M, Wei W, Guo RP
Published 2021-03-01

Clinical Outcomes and Prognosis Factors of Nivolumab Plus Chemotherapy or Multitarget Tyrosine Kinase Inhibitor in Multi-Line Therapy for Recurrent Hepatitis B Virus-Related Hepato...

by Chao Chen, Li An, Ying Cheng, Xianwen Luo, Zixiong Li, Xiufeng Liu
Published 2020-08-01

Ultraviolet Radiation and Melanomagenesis: From Mechanism to Immunotherapy

by Xiaoying Sun, Xiaoying Sun, Na Zhang, Chengqian Yin, Bo Zhu, Xin Li, Xin Li
Published 2020-07-01

The Inhibitory T Cell Receptors PD1 and 2B4 Are Differentially Regulated on CD4 and CD8 T Cells in a Mouse Model of Non-alcoholic Steatohepatitis

by Cordula Hansel, Stephanie Erschfeld, Maike Baues, Twan Lammers, Ralf Weiskirchen, Christian Trautwein, Daniela C. Kroy, Hannah K. Drescher
Published 2019-03-01

New Progress in the Relationship between Immune Cells, PD-1 
in Tumor Microenvironment and the Efficacy of EGFR-TKIs

by Shiyang YUAN, Hui XU, Junping XIE
Published 2017-11-01

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma

by Hassan Sadozai, Thomas Gruber, Robert Emil Hunger, Mirjam Schenk
Published 2017-12-01

A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab

by Annie A. Guedikian, Megan E. Randall, Anita Sharko, William T. Leslie
Published 2021-09-01

Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study

by Ya Chen, Yanan Wang, Zhengyu Yang, Minjuan Hu, Yanwei Zhang, Fangfei Qian, Wei Zhang, Bo Zhang, Baohui Han
Published 2021-06-01

PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective

by HaiXia Li, Chao Zheng, Jinming Han, Jinming Han, Jie Zhu, Jie Zhu, Shan Liu, Tao Jin
Published 2021-07-01

Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer

by Stephan Kruger, Marie-Louise Legenstein, Verena Rösgen, Michael Haas, Dominik Paul Modest, Christoph Benedikt Westphalen, Steffen Ormanns, Thomas Kirchner, Volker Heinemann, Stefan Holdenrieder, Stefan Boeck
Published 2017-05-01

Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy

by Muhammad Khan, Muhammad Khan, Zhihong Zhao, Sumbal Arooj, Sumbal Arooj, Yuxiang Fu, Guixiang Liao
Published 2020-11-01

Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management

by Yu-Wen Zhou, Ya-Juan Zhu, Man-Ni Wang, Yao Xie, Chao-Yue Chen, Tao Zhang, Fan Xia, Zhen-Yu Ding, Ji-Yan Liu
Published 2019-11-01

Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection

by Maike Sperk, Robert van Domselaar, Ujjwal Neogi
Published 2018-07-01

Bullous pemphigoid associated with cemiplimab therapy in a patient with locally advanced cutaneous squamous cell carcinoma

by Cesar A. Virgen, MD, PhD, Tuyet A. Nguyen, MD, Cosimo Di Raimondo, MD, Arya Amini, MD, Kim A. Margolin, MD, Vishwas Parekh, MD, Farah R. Abdulla, MD, Badri Modi, MD
Published 2020-03-01

PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics

by Margarita Udall, Maria Rizzo, Juliet Kenny, Jim Doherty, SueAnn Dahm, Paul Robbins, Eric Faulkner
Published 2018-02-01

Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors

by Ewelina Grywalska, Małgorzata Sobstyl, Lechosław Putowski, Jacek Roliński
Published 2019-09-01